β-Adrenergic-mediated vasodilation in young men and women: Cyclooxygenase restrains nitric oxide synthase

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 6, 2016, Pages H756-H764

  Limberg, Jacqueline K ^a   Johansson, Rebecca E ^a   Peltonen, Garrett L ^a   Harrell, John W ^a   Kellawan, J Mikhail ^a   Eldridge, Marlowe W ^a,b   Sebranek, Joshua J ^b   Schrage, William G ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Blood flow; Isoproterenol; Prostaglandin; Sex differences; Skeletal muscle

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE; KETOROLAC TROMETAMOL; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; KETOROLAC; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; ENZYME INHIBITION; FEMALE; FOLLICULAR PHASE; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; VASODILATATION; ANTAGONISTS AND INHIBITORS; DOPPLER ULTRASONOGRAPHY; DRUG EFFECTS; FOREARM; INTRAARTERIAL DRUG ADMINISTRATION; MICROCIRCULATION; PHYSIOLOGY; VASCULARIZATION;

ADRENERGIC BETA-AGONISTS; ADULT; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; FEMALE; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; ISOPROTERENOL; KETOROLAC; MALE; MICROCIRCULATION; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEX FACTORS; ULTRASONOGRAPHY, DOPPLER; VASODILATION;

EID: 84983732539     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00886.2015     Document Type: Article

References (46)

1. Amenta F, Coppola L, Gallo P, Ferrante F, Forlani A, Monopoli A, Napoleone P. Autoradiographic localization of beta-adrenergic receptors in human large coronary arteries. Circ Res 68: 1591-1599, 1991.
2. Bea ML, Ghaleh B, Giudicelli JF, Berdeaux A. Lack of importance of NO in beta-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries. Br J Pharmacol 111: 981-982, 1994.
3. Brousseau D, Desjardins JF, Jasmin G, Dumont L. Altered coronary and cardiac adrenergic response in the failing hamster heart: role of cyclooxygenase derivatives. Can J Physiol Pharmacol 80: 218-225, 2002.
4. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd, Panza JA. Decreased vasodilator response to isoproterenol during nitric oxide inhi-bition in humans. Hypertension 30: 918-921, 1997.
5. Casey DP, Ranadive SM, Joyner MJ. Aging is associated with altered vasodilator kinetics in dynamically contracting muscle: role of nitric oxide. J Appl Physiol 119: 232-241, 2015.
6. Casey DP, Walker BG, Curry TB, Joyner MJ. Ageing reduces the compensatory vasodilatation during hypoxic exercise: the role of nitric oxide. J Physiol 589: 1477-1488, 2011.
7. Crecelius AR, Kirby BS, Hearon CM Jr, Luckasen GJ, Larson DG, and Dinenno FA. Contracting human skeletal muscle maintains the ability to blunt alpha1-adrenergic vasoconstriction during KIR channel and Na() /K()-ATPase inhibition. J Physiol 593: 2735-2751, 2015.
8. Crecelius AR, Kirby BS, Richards JC, Garcia LJ, Voyles WF, Larson DG, Luckasen GJ, Dinenno FA. Mechanisms of ATP-mediated vasodi-lation in humans: modest role for nitric oxide and vasodilating prostaglan-dins. Am J Physiol Heart Circ Physiol 301: H1302-H1310, 2011.
9. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 95: 2293-2297, 1997.
10. Eisenach JH, Schroeder DR, Pavey ES, Penheiter AR, Knutson JN, Turner ST, Joyner MJ. Interactions between beta-2 adrenoceptor gene variation, cardiovascular control and dietary sodium in healthy young adults. J Physiol 592: 5221-5233, 2014.
11. Eisenach JH, Schroeder DR, Pike TL, Johnson CP, Schrage WG, Snyder EM, Johnson BD, Garovic VD, Turner ST, Joyner MJ. Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans. J Physiol 574: 955-965, 2006.
12. Ferro A, Queen LR, Priest RM, Xu B, Ritter JM, Poston L, Ward JP. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 126: 1872-1880, 1999.
13. Gao F, de Beer VJ, Hoekstra M, Xiao C, Duncker DJ, Merkus D. Both beta1-and beta2-adrenoceptors contribute to feedforward coronary resis-tance vessel dilation during exercise. Am J Physiol Heart Circ Physiol 298: H921-H929, 2010.
14. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 107: 684-690, 1992.
15. Greaney JL, Stanhewicz AE, Kenney WL, Alexander LM. Lack of limb or sex differences in the cutaneous vascular responses to exogenous norepinephrine. J Appl Physiol 117: 1417-1423, 2014.
16. Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach J, Joyner MJ. Sex and ageing differences in resting arterial pressure regulation: the role of the beta-adrenergic receptors. J Physiol 589: 5285-5297, 2011.
17. Harvey RE, Barnes JN, Charkoudian N, Curry TB, Eisenach JH, Hart EC, Joyner MJ. Forearm vasodilator responses to a beta-adrenergic receptor agonist in premenopausal and postmenopausal women. Physiol Rep 2: e12032, 2014.
18. Herr MD, Hogeman CS, Koch DW, Krishnan A, Momen A, Leuen-berger UA. A real-time device for converting Doppler ultrasound audio signals into fluid flow velocity. Am J Physiol Heart Circ Physiol 298: H1626-H1632, 2010.
19. Hogarth AJ, Mackintosh AF, Mary DA. Gender-related differences in the sympathetic vasoconstrictor drive of normal subjects. Clin Sci (Lond) 112: 353-361, 2007.
20. Joyner MJ, Dietz NM, Shepherd JT. From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. J Appl Physiol 91: 2431-2441, 2001.
21. Kellawan JM, Johansson RE, Harrell JW, Sebranek JJ, Walker BJ, Eldridge MW, Schrage WG. Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase. Eur J Appl Physiol 115: 1735-1746, 2015.
22. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36: 1233-1238, 2000.
23. Limberg JK, Eldridge MW, Proctor LT, Sebranek JJ, Schrage WG. Alpha-adrenergic control of blood flow during exercise: effect of sex and menstrual phase. J Appl Physiol 109: 1360-1368, 2010.
24. Limberg JK, Harrell JW, Johansson RE, Eldridge MW, Proctor LT, Sebranek JJ, Schrage WG. Microvascular function in younger adults with obesity and metabolic syndrome: role of oxidative stress. Am J Physiol Heart Circ Physiol 305: H1230-H1237, 2013.
25. Malik KU. Interaction of arachidonic acid metabolites and adrenergic nervous system. Am J Med Sci 295: 280-286, 1988.
26. Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med 4: 10-13, 20, 2001.
27. Medow MS, Taneja I, Stewart JM. Cyclooxygenase and nitric oxide synthase dependence of cutaneous reactive hyperemia in humans. Am J Physiol Heart Circ Physiol 293: H425-H432, 2007.
28. Miller RC, Cornish EJ, Goldie RG. Potentiating effect of indomethacin on relaxations of sheep isolated coronary artery caused by sympathetic nerve stimulation or exogenous noradrenaline. Pharmacol Res Commun 16: 31-39, 1984.
29. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. Modula-tion of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57: 217-252, 2005.
30. Murphree SS, Saffitz JE. Delineation of the distribution of beta-adrenergic receptor subtypes in canine myocardium. Circ Res 63: 117-125, 1988.
31. Ozkor MA, Murrow JR, Rahman AM, Kavtaradze N, Lin J, Mana-tunga A, Quyyumi AA. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease. Circulation 123: 2244-2253, 2011.
32. Peltonen GL, Harrell JW, Rousseau CL, Ernst BS, Marino ML, Crain MK, Schrage WG. Cerebrovascular regulation in men and women: stimulus-specific role of cyclooxygenase. Physiol Rep 3: e12451, 2015.
33. Ranadive SM, Joyner MJ, Walker BG, Taylor JL, Casey DP. Effect of vitamin C on hyperoxia-induced vasoconstriction in exercising skeletal muscle. J Appl Physiol 117: 1207-1211, 2014.
34. Ruan Y, Kan H, Malik KU. Beta adrenergic receptor stimulated prosta-cyclin synthesis in rabbit coronary endothelial cells is mediated by selective activation of phospholipase D: inhibition by adenosine 3=5=-cyclic monophosphate. J Pharmacol Exp Ther 281: 1038-1046, 1997.
35. Rubanyi G, Paul RJ. O 2-sensitivity of beta adrenergic responsiveness in isolated bovine and porcine coronary arteries. J Pharmacol Exp Ther 230: 692-698, 1984.
36. Rubanyi G, Vanhoutte PM. Inhibitors of prostaglandin synthesis aug-ment beta-adrenergic responsiveness in canine coronary arteries. Circ Res 56: 117-125, 1985.
37. Rubanyi GM, Paul RJ. Modulation of beta adrenergic responsiveness by arachidonic acid metabolites in isolated bovine coronary arteries. J Phar-macol Exp Ther 234: 555-560, 1985.
38. Schrage WG, Dietz NM, Eisenach JH, Joyner MJ. Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle. J Appl Physiol 98: 1251-1257, 2005.
39. Schwartz J, Velly J. The beta-adrenoceptor of pig coronary arteries: determination of beta 1 and beta 2 subtypes by radioligand binding. Br J Pharmacol 79: 409-414, 1983.
40. Shaffer JE, Malik KU. Enhancement of prostaglandin output during activation of beta-1 adrenoceptors in the isolated rabbit heart. J Pharmacol Exp Ther 223: 729-735, 1982.
41. Stein M, Deegan R, He H, Wood AJ. Beta-adrenergic receptor-mediated release of norepinephrine in the human forearm. Clin Pharmacol Ther 54: 58-64, 1993.
42. Sunahara FA, Talesnik J. Prostaglandin inhibition of metabolically induced coronary vasodilation. J Pharmacol Exp Ther 188: 135-147, 1974.
43. Talesnik J, Sunahara FA. Enhancement of metabolic coronary dilatation by aspirin-like substances by suppression of prostaglandin feedback con-trol? Nature 244: 351-353, 1973.
44. Tang M, Cyrus T, Yao Y, Vocun L, Pratico D. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E-and LDL receptor-deficient mice. Circulation 112: 2867-2874, 2005.
45. Toda N, Okamura T. Beta adrenoceptor subtype in isolated human, monkey and dog epicardial coronary arteries. J Pharmacol Exp Ther 253: 518-524, 1990.
46. Yamada T, Fujino T, Yuhki K, Hara A, Karibe H, Takahata O, Okada Y, Xiao CY, Takayama K, Kuriyama S, Taniguchi T, Shioko-shi T, Ohsaki Y, Kikuchi K, Narumiya S, Ushikubi F. Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase. Circulation 108: 2381-2386, 2003.